Aclaris Therapeutics to Participate in Two March Healthcare Conferences
Aclaris Therapeutics (NASDAQ: ACRS), a clinical-stage biopharmaceutical company specializing in immuno-inflammatory diseases, has announced its participation in two major healthcare conferences this March.
The company's leadership team, led by CEO Dr. Neal Walker, will engage in:
- A fireside chat at the Leerink Partners Global Healthcare Conference in Miami, Florida on March 11, 2025, at 3:00 PM EDT
- A virtual fireside chat during the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference on March 27, 2025, at 9:00 AM EDT
Both events will be webcast live and archived on the Events page of Aclaris' website, remaining accessible for at least 30 days following the presentations.
Aclaris Therapeutics (NASDAQ: ACRS), un'azienda biofarmaceutica in fase clinica specializzata in malattie immuno-infiammatorie, ha annunciato la sua partecipazione a due importanti conferenze sanitarie questo marzo.
Il team dirigenziale dell'azienda, guidato dal CEO Dr. Neal Walker, parteciperà a:
- Una chiacchierata informale alla Leerink Partners Global Healthcare Conference a Miami, Florida, l'11 marzo 2025, alle 15:00 EDT
- Una chiacchierata informale virtuale durante la H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference il 27 marzo 2025, alle 9:00 EDT
Entrambi gli eventi saranno trasmessi in diretta e archiviati nella pagina Eventi del sito web di Aclaris, rimanendo accessibili per almeno 30 giorni dopo le presentazioni.
Aclaris Therapeutics (NASDAQ: ACRS), una empresa biofarmacéutica en etapa clínica especializada en enfermedades inmuno-inflamatorias, ha anunciado su participación en dos importantes conferencias de salud este marzo.
El equipo directivo de la empresa, encabezado por el CEO Dr. Neal Walker, participará en:
- Una charla informal en la Leerink Partners Global Healthcare Conference en Miami, Florida, el 11 de marzo de 2025, a las 3:00 PM EDT
- Una charla informal virtual durante la H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference el 27 de marzo de 2025, a las 9:00 AM EDT
Ambos eventos se transmitirán en vivo y se archivarán en la página de Eventos del sitio web de Aclaris, permaneciendo accesibles durante al menos 30 días después de las presentaciones.
Aclaris Therapeutics (NASDAQ: ACRS)는 면역-염증 질환을 전문으로 하는 임상 단계의 생명공학 회사로, 이번 3월에 두 개의 주요 의료 회의에 참여한다고 발표했습니다.
회사의 리더십 팀은 CEO Dr. Neal Walker의 주도로 다음과 같은 행사에 참여할 예정입니다:
- 2025년 3월 11일 플로리다 마이애미에서 열리는 Leerink Partners Global Healthcare Conference에서의 대화
- 2025년 3월 27일 오전 9시 EDT에 열리는 H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference에서의 가상 대화
두 이벤트 모두 실시간으로 방송되며 Aclaris 웹사이트의 이벤트 페이지에 아카이브되어 발표 후 최소 30일 동안 접근할 수 있습니다.
Aclaris Therapeutics (NASDAQ: ACRS), une entreprise biopharmaceutique en phase clinique spécialisée dans les maladies immuno-inflammatoires, a annoncé sa participation à deux grandes conférences de santé en mars.
La direction de l'entreprise, dirigée par le PDG Dr. Neal Walker, participera à :
- Un entretien informel lors de la Leerink Partners Global Healthcare Conference à Miami, Floride, le 11 mars 2025 à 15h00 EDT
- Un entretien informel virtuel lors de la H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference le 27 mars 2025 à 9h00 EDT
Les deux événements seront diffusés en direct et archivés sur la page Événements du site web d'Aclaris, restant accessibles pendant au moins 30 jours après les présentations.
Aclaris Therapeutics (NASDAQ: ACRS), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf immun-inflammatorische Erkrankungen spezialisiert hat, hat seine Teilnahme an zwei wichtigen Gesundheitskonferenzen im März angekündigt.
Das Führungsteam des Unternehmens, geleitet von CEO Dr. Neal Walker, wird an folgenden Veranstaltungen teilnehmen:
- Ein informelles Gespräch auf der Leerink Partners Global Healthcare Conference in Miami, Florida, am 11. März 2025 um 15:00 Uhr EDT
- Ein virtuelles informelles Gespräch während der H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference am 27. März 2025 um 9:00 Uhr EDT
Beide Veranstaltungen werden live übertragen und auf der Veranstaltungsseite der Aclaris-Website archiviert, sodass sie mindestens 30 Tage nach den Präsentationen zugänglich bleiben.
- None.
- None.
WAYNE, Pa., March 04, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in March.
- On Tuesday March 11, 2025, at 3:00 PM EDT, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Leerink Partners Global Healthcare Conference in Miami, Florida.
- On Thursday March 27, 2025, at 9:00 AM EDT, Dr. Walker and other members of Aclaris’ senior leadership team will participate in a virtual fireside chat during the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
A live and archived webcast of both events will be accessible on the Events page of https://www.aclaristx.com/. The webcasts will be available on the Aclaris website for at least 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on X (formerly Twitter) at @AclarisTx and on LinkedIn.
Aclaris Therapeutics Contact:
Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com
FAQ
When is Aclaris Therapeutics (ACRS) presenting at the Leerink Partners Conference in March 2025?
How can investors watch Aclaris Therapeutics' (ACRS) March 2025 conference presentations?
What healthcare conferences is Aclaris Therapeutics (ACRS) attending in March 2025?
When is Aclaris (ACRS) participating in the H.C. Wainwright Virtual Conference?
